In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
2026-03-12 04:04:00 ET
A multibagger stock is one that has doubled your money or more. Peter Lynch, the highly respected investment manager who ran the Magellan Fund for 14 years, coined the term in his book, One Up on Wall Street. He uses baseball lingo -- where "sacks" or "bags" represent bases -- to describe how many times an investor has "run the bases" with a single stock.
Regeneron Pharmaceuticals (NASDAQ: REGN) is a leading biotech company that has been a steady, if not spectacular performer, delivering a 106% gain over the past decade. Despite that, the company has the potential to double investors' returns in the next few years, making it a two-bagger.
That potential lies in the company's promising pipeline, which includes 26 candidates in late-stage trials.
NASDAQ: REGN
REGN Trading
-1.59% G/L:
$742.885 Last:
150,713 Volume:
$754.55 Open:
